ENSILICATED TECHNOLOGIES LTD
Executive Summary
Ensilicated Technologies Ltd is an early-stage biotechnology company with solid net current assets and cash reserves but increasing short-term liabilities and widening losses. The company’s ongoing viability depends on continued investor support amid typical start-up operating losses. No regulatory compliance issues are evident, but investor due diligence should focus on liquidity management and funding sustainability.
View Full Analysis Report →- Legal registered address
- Science Creates St Philips Albert Road St. Philips Bristol England BS2 0XJ Copied!
Latest financial results as of 1 August 2025- Cash in bank
- £363.06k
- Current assets
- £566.73k
- Fixed assets
- £85.28k
- Current creditors
- £200.88k
- Shareholders funds
- £866.28k
View full financial accounts- Cash in bank
- £363.06k
- Current assets
- £566.73k
- Fixed assets
- £85.28k
- Current creditors
- £200.88k
- Shareholders funds
- £866.28k
- Company number
- 13537400 Copied!
Accounts
Latest annual accounts were to 31 July 2023
Next annual accounts are due by 31 July 2025
Company financial year end is on 31 July 2026
Confirmation statement
Latest confirmation statement statement dated 28 July 2024
Next statement due by 11 August 2025
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Latest company documents
Date | Description |
---|---|
11/08/2411 August 2024 | Confirmation statement made on 2024-07-28 with updates |
31/07/2431 July 2024 | Annual accounts for year ending 31 Jul 2024 |
24/07/2424 July 2024 | Sub-division of shares on 2024-04-22 |
15/04/2415 April 2024 | Total exemption full accounts made up to 2023-07-31 |
16/12/2316 December 2023 | Appointment of Ms Sarah Jane Pollitt as a director on 2023-12-06 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company